Charles Schwab Investment Management Inc Organogenesis Holdings Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 958,700 shares of ORGO stock, worth $4.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
958,700
Previous 835,046
14.81%
Holding current value
$4.34 Million
Previous $3.61 Million
2.74%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ORGO
# of Institutions
126Shares Held
71.8MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...